MENU
ABOS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Acumen Pharmaceuticals (ABOS) Ownership - Who owns Acumen Pharmaceuticals?

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease... Show more

Profile

Industry
N/A
Address
1210-1220 Washington Street
Phone
+1 617 344-4190
Employees
61
Web
https://www.acumenpharm.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
172.26M
P/E Ratio
N/A
Total Cash
128.4M
Projected Growth
N/A
Total Debt
31.16M
Revenue
N/A
Risk (Beta)
2.72
Dividend Yield
N/A
Total Cash/Share
1.78
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
ABOS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
1210-1220 Washington Street
Phone
+1 617 344-4190
Employees
61
Web
https://www.acumenpharm.com